Valuation: DreamCIS, Inc.

Market Cap 74.54B 50.13M 43.81M 40.42M 37.26M 70.23M 4.83B 71.79M 483M 190M 2.36B 188M 184M 8.14B P/E 2026 *
7.59x
P/E 2027 * 5.64x
Enterprise Value 31.54M 21.21K 18.54K 17.1K 15.77K 29.72K 2.04M 30.37K 204K 80.41K 1M 79.65K 77.91K 3.44M EV / Sales 2026 *
0.35x
EV / Sales 2027 * 0.2x
Free-Float
30.37%
Yield 2026 *
-
Yield 2027 * -
03-22 DreamCIS, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 CI
12-01 Curi Bio, Inc. announced that it has received $10 million in funding from DreamCIS, Inc. CI
11-10 DreamCIS, Inc. agreed to acquire 13.01% stake in Curi Bio, Inc. CI
11-10 Curi Bio, Inc. announced that it expects to receive $14.848537 million in funding from DreamCIS, Inc. CI
25-09-29 DreamCIS, Inc. announced that it has received KRW 15 billion in funding from Hong Kong Tigermed Co., Ltd., NH Investment & Securities Co., Ltd., KB Securities Co., Ltd., Korea Investment & Securities Co., Ltd. CI
25-09-21 DreamCIS, Inc. announced that it expects to receive KRW 15 billion in funding from Hong Kong Tigermed Co., Ltd., NH Investment & Securities Co., Ltd., KB Securities Co., Ltd., Korea Investment & Securities Co., Ltd. and other investors CI
24-02-22 Curi Bio, Genetox and DreamCIS Sign MOU for Strategic Collaboration on 3D Neuromuscular Junction Model for Botox Potency Assay CI
23-12-21 T&R Biofab Co., Ltd. announced that it has received KRW 1.999996 billion in funding from Korea Investment Partners Co. Ltd., DreamCIS, Inc. CI
23-12-13 T&R Biofab Co., Ltd. announced that it expects to receive KRW 1.999996 billion in funding from Korea Investment Partners Co. Ltd., DreamCIS, Inc. CI
23-03-21 DreamCIS, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
22-03-27 DreamCIS, Inc. announced that it has received KRW 2.9999925 billion in funding CI
22-03-16 DreamCIS, Inc. announced that it expects to receive KRW 2.9999925 billion in funding CI
20-05-21 DreamCIS, Inc. has completed an IPO in the amount of KRW 20.186311 billion. CI
1 day-3.19%
1 week-6.34%
Current month-8.73%
1 month-14.89%
3 months-39.88%
6 months-51.67%
Current year-52.51%
1 week 2,845
Extreme 2845
3,160
1 month 2,845
Extreme 2845
3,630
Current year 2,845
Extreme 2845
8,640
1 year 2,845
Extreme 2845
8,640
3 years 2,435
Extreme 2435
9,750
5 years 2,370
Extreme 2370
9,750
10 years 2,370
Extreme 2370
9,750
Manager TitleAgeSince
Chief Executive Officer 56 2022-03-29
Director of Finance/CFO 57 2016-04-30
Director TitleAgeSince
Director/Board Member 45 2019-08-29
Director/Board Member 57 2016-04-30
Director/Board Member 53 2019-08-29
Date Insider Type Main position Quantity % Market Cap.
12/16/24 Buy

Chief Executive Officer

30,000 0.1261%
Change 5-day change 1-year change 3-year change Capi.($)
-3.19%-6.34%-16.07%+0.58% 50.13M
+0.58%+0.53%+95.39%+461.54% 38.87B
+0.50%+2.37%+16.26%+30.51% 23.24B
-0.91%+3.58%-20.59%-38.18% 7.55B
-1.27%-5.20%+8.18%+81.31% 4.89B
+0.84%-1.41%+14.39%+44.85% 2.93B
-1.55%+3.54%+134.13%-18.15% 1.9B
+2.90%-3.29%-18.48%+704.56% 1.88B
-5.48%+7.11%-10.82%-62.28% 1.8B
+1.04%+1.04%+31.35%+9.22% 1.76B
Average -0.66%-0.25%+23.37%+121.40% 8.49B
Weighted average by Cap. +0.21%+0.92%+50.28%+236.66%

Financials

2026 *2027 *
Net sales 90B 60.52M 52.89M 48.81M 44.99M 84.79M 5.83B 86.68M 583M 229M 2.85B 227M 222M 9.83B 117B 78.58M 68.67M 63.37M 58.41M 110M 7.57B 113M 757M 298M 3.71B 295M 289M 12.76B
Net income 9.8B 6.59M 5.76M 5.31M 4.9M 9.23M 635M 9.44M 63.52M 24.99M 311M 24.75M 24.21M 1.07B 13.2B 8.88M 7.76M 7.16M 6.6M 12.44M 855M 12.71M 85.56M 33.65M 419M 33.34M 32.61M 1.44B
Net Debt -43B -28.92M -25.27M -23.32M -21.49M -40.51M -2.78B -41.41M -279M -110M -1.36B -109M -106M -4.7B -51B -34.3M -29.97M -27.66M -25.49M -48.05M -3.3B -49.12M -331M -130M -1.62B -129M -126M -5.57B
Logo DreamCIS, Inc.
DreamCIS Inc is a Korea-based company principally engaged in the business of contract clinical trial. The Company mainly provides services include regulatory post-marketing surveillance (rPMS), clinical trial, non-interventional study (NIS) and others. The Company provides its services within domestic market and to overseas markets.
Employees
391
Date Price Change Volume
26-07-16 ₩3,030.00 -3.19% 31,075
26-07-15 ₩3,130.00 +4.68% 43,861
26-07-14 ₩2,990.00 -0.50% 96,086
26-07-13 ₩3,005.00 -7.11% 60,088
Trader
-
Investor
-
Global
-
Quality
ESG MSCI
-

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A223250 Stock